loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

Approved Drug Products containing 204237 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 RUBICON (1)

filter

01 TABLET, DELAYED RELEASE;ORAL (1)

filter

01 RX (1)

filter

01 RABEPRAZOLE SODIUM (1)

filter

01 No (1)

URL Supplier Web Content
TABLET, DELAYED RE...
20MG
2015-11-18
204237
RABEPRAZOLE SODIUM
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 204237

Looking for FDA Orange Book APPLICATION 204237 1

19

Rubicon Research Pvt. Ltd., based in India, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is RABEPRAZOLE SODIUM, with a corresponding application number 204237.

Regulatory Information RX

With a dosage strength 20MG

Dosage Form Route TABLET, DELAYED RELEASE; ORAL

Reference Listed Drug No

Approved since 2015-11-18

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY